When it comes to weight loss solutions, patients often face not only medical but also significant financial decisions. Two popular paths to sustained weight loss are gastric sleeve (VSG) surgery and GLP-1 medications such as Wegovy (semaglutide). Both options are proven to help patients lose weight but understanding the cost-effectiveness of each can be important for long-term planning.
Gastric Sleeve Surgery: A One-Time Investment
Gastric sleeve surgery, currently offered to self-pay patients for $10,000 at JourneyLite Surgery Center, is a one-time procedure that involves removing part of the stomach to reduce its size, thereby limiting food intake and promoting weight loss. While the upfront cost is higher, its long-term benefits can outweigh this initial expense. The procedure usually leads to significant weight loss (greater than with a GLP-1) and improvements in obesity-related conditions, such as type 2 diabetes, sleep apnea, and hypertension, potentially reducing future healthcare costs.
Although a higher up-front cost can be daunting, one benefit is that this amount is much more likely to exceed the threshold of 7.5% of adjusted gross income, which likely means the expense will be tax deductible.
Moreover, the surgery does not require ongoing monthly expenses or subscriptions. It also avoids potentially unknown risks of GLP-1 injections over many decades. After the procedure, patients may need to invest in vitamins, follow-up appointments, or diet modifications, but these costs are generally minor compared to the cumulative price of lifelong medication.
Wegovy: A Lifelong Commitment
Wegovy, on the other hand, is an injectable medication that works by regulating appetite and helping individuals feel full longer. While effective, the medication can cost approximately $1,300 per month without insurance coverage. Over a year, this amounts to $15,600, and over a decade, $156,000—far surpassing the one-time cost of gastric sleeve surgery. Even with the current temporary discounted pricing from the manufacturer, it would still cost nearly $60,000 over 10 years (assuming this discount is even continued). For someone planning to use Wegovy indefinitely, the financial commitment can become a significant burden.
Additionally, Wegovy’s cost is recurring, meaning patients must continuously invest in it to maintain its weight loss benefits. If patients discontinue the medication, they will likely experience weight regain, wiping out their earlier progress and investment.
Comparing Effectiveness of Gastric Sleeve vs. Wegovy
While both options are effective for weight loss, their outcomes depend on individual factors such as adherence to lifestyle changes, underlying health conditions, and personal preferences. Gastric sleeve surgery tends to lead to more dramatic and sustained weight loss, while Wegovy provides flexibility and avoids surgical risks.
Conclusion:
From a purely cost-effective standpoint, gastric sleeve surgery presents a clear advantage for individuals seeking a long-term solution. The upfront cost of $10,000 is dwarfed by the expense of Wegovy over a lifetime, even if additional post-surgery expenses are considered. For those weighing their options, this one-time investment will likely lead to significant savings, better weight loss, and higher long-term success.
Ultimately, the choice between gastric sleeve surgery and Wegovy will depend on personal preferences, medical advice, and financial considerations. One of our expert physicians can provide further insight into which option aligns best with your goals and circumstances. Make an appointment if you would like to learn more!
